Advocacy intelligence hub — real-time data for patient organizations
Gylden Pharma Ltd — EARLY_PHASE1
Bavarian Nordic — PHASE3
Centre Hospitalier Universitaire de la Réunion — NA
Butantan Institute — PHASE3
Valneva Austria GmbH
Valneva Austria GmbH
Valneva Austria GmbH
Hospital Israelita Albert Einstein
Jiangsu Kanion Pharmaceutical Co., Ltd — NA
Data from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.
FINANCIAL LANDSCAPE SUMMARY
Total programs
Andre Cabie, MD
Centre Hospitalier Universitaire (CHU), Martinique
Bruno Hoen, MD
University Hospital Pointe-a-Pitre, Guadeloupe
Patrick Ajiboye, MD, MD
Bavarian Nordic
📍 MERIDIAN, MS
Myrielle Dupont-Rouzeyrol, PhD
Institut Pasteur de Nouvelle-Calédonie
James McCarty, MD
Emergent BioSolutions
Clemente Diaz, MD, MD
Puerto Rico Clinical and Translational Research Consortium
📍 RICHWOOD, WV